Trial intelligence / Profile preview

NGX-1998 in Postherpetic Neuralgia

NCT01228838Phase 2Completed

Sponsor
NeurogesX
Start
Oct 2010
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of NGX-1998 in postherpetic neuralgia (PHN), sponsored by NeurogesX. Started Oct 2010; status: completed.

02

Drugs

NGX-1998
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT01228838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01228838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call